Satellite programs offer sponsors the opportunity to provide professional attendees with comprehensive insights into important interventional topics and issues facing today's specialists. The satellite program schedule is comprised of Breakfast Meetings, Presentation Theater Programs (lunch sessions), and Evening Programs.


Satellite Programs

TAVR in 2016: Realities and Controversies!

Presentation Theater Program

10/30/2016 13:00:00 10/30/2016 14:00:00 TAVR in 2016: Realities and Controversies! TCT 2017 true MM/DD/YYYY TCT 2014 Satellite Symposia - Presentation Theater Program

Sunday, October 30, 2016
Program: 1:00 pm-2:00 pm
Walter E. Washington Convention Center, Washington, D.C., Presentation Theater 1

TAVR in 2016: Realities and Controversies!

TAVR in 2016: Realities and Controversies!

Sponsored by Cardiovascular Research Foundation

Supported through an educational grant from Edwards Lifesciences

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cardiovascular Research Foundation designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Martin B. Leon, MD

NewYork-Presbyterian Hospital/Columbia University Medical Center

New York, NY


Michael J. Mack, MD

The Heart Hospital Baylor Plano

Plano, TX


Vasilis Babaliaros, MD

Emory University School of Medicine

Atlanta, GA


Philippe Genereux, MD

Columbia University Medical Center/Hôpital du Sacré-Coeur de Montréal

New York, NY


1:00 pm

Reality #1: Which Intermediate-Risk Patients are Candidates for TAVR vs. SAVR?

Michael J. Mack

1:10 pm

Controversy #1: How Should Potential Durability Differences Influence TAVR vs. SAVR Choices in Younger and Lower Risk Patients?

Martin B. Leon

1:20 pm

Reality #2: How to Optimize the Clinical Care Pathway: From Referral to Treatment to Safe (Early) Discharge Home

Vasilis Babaliaros

1:30 pm

Controversy #2: The Evidence Pathway from Inoperable to Asymptomatic AS

Philippe Genereux

1:40 pm

Roundtable Discussion

2:00 pm